Decreased levels of active SMAD2 correlate with poor prognosis in gastric cancer.
Wu Y, Li Q, Zhou X, Yu J, Mu Y, Munker S, Xu C, Shen Z, Müllenbach R, Liu Y, Li L, Gretz N, Zieker D, Li J, Matsuzaki K, Li Y, Dooley S, Weng H.
Wu Y, et al. Among authors: shen z.
PLoS One. 2012;7(4):e35684. doi: 10.1371/journal.pone.0035684. Epub 2012 Apr 23.
PLoS One. 2012.
PMID: 22539990
Free PMC article.